A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults
Clinical trial NCT01144299 · COMPLETED
Trial details
- NCT number
- NCT01144299
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-17
- Primary completion
- 2010-07-10
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.